Zymergi LogoCart

483 Document: Nephron Pharmaceuticals, Dec 2, 2022

FDANews 483 Nephron Pharmaceuticals Dec 2 2022 top
Robert J. Ham FDA Investigator Logan T. Williams FDA Investigator

On Dec 02, 2022, the FDA inspected Nephron Pharmaceuticals's Murray site. Explore the inspectional observations.